ENTIS members from the Berlin TIS (Embryotox) have published a comparative cohort study investigating pregnancy outcomes for pregnancies exposed to levetiracetam. More information can be found here.
» Read more
Researchers affiliated with the Pregnancy Inflammatory bowel disease And Neonatal Outcomes (PIANO) registry have published a study of pregnancy and infant outcomes following maternal vedolizumab and ustekinumab use in pregnancy. More information can be found here.
» Read more
Researchers affiliated to The AVONEX® Pregnancy Exposure Registry (Biogen) have published a case series of 306 pregnancy outcomes for a cohort of women with multiple sclerosis who used intramuscular interferon beta-1a during the first trimester. More information available here. Photo by Mufid Majnun on Unsplash
» Read more
Between the 31st August and 2nd September 2023, the team from the Irish Medicines in Pregnancy Service based at the Rotunda Hospital in Dublin hosted the 34th ENTIS conference in Dublin, Ireland Delegates were treated to some fantastic presentations, including a pre-conference education course. The meeting was a great success, and warm thanks are extended to the whole of the […]
» Read more
See here for the latest announcement about the 2024 joint ENTIS-OTIS meeting in Nyborg, Denmark.
» Read more
In 2022, the European Society for Medical Oncology held a virtual meeting to gain insights from a multidisciplinary group of experts and develop statements about the management of breast cancer during pregnancy. The recommendations are available here. Photo by Anastasiia Chepinska on Unsplash
» Read more
The Italian Societies of Toxicology, Neuropsychopharmacology, Psychiatry, Obstetrics and Gynecology, Drug Addiction, and Addiction Pathology have published joint consensus recommendations regarding the management of depressive disorders in pregnancy. These recommendations focussed on five key areas including: (i) the importance of management of anxiety and depressive disorders in pregnancy; (ii) the overall risk of malformation with antidepressant and anxiolytic drugs; (iii) […]
» Read more
Researchers affiliated to the Poison Control Center and Teratology Information Center in Bergamo, Italy, have published a case series of regnancy and fetal outcomes following maternal use of long-acting injectable antipsychotics. More information is available here. Photo by Mufid Majnun on Unsplash
» Read more
Researchers from Teva Pharmaceuticals and St. Josef-Hospital (Bochum, Germany) have published the pregnancy and fetal outcomes for a cohort of 618 women who used glatiramer acetate in all three trimesters of pregnancy. More information can be found here.
» Read more
This year’s annual conference will be held at the Royal College of Surgeons in Ireland, in Dublin, from 31st August to the 2nd September. The conference organising committee at the Irish Medicines in Pregnancy Service (Rotunda Hospital, Dublin) have released the conference programme, which is available here.
» Read more